KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Gilead Sciences (GILD) Long-Term Deferred Tax (2016 - 2025)

Gilead Sciences' Long-Term Deferred Tax history spans 11 years, with the latest figure at $2.0 billion for Q4 2025.

For Q4 2025, Long-Term Deferred Tax fell 17.41% year-over-year to $2.0 billion; the TTM value through Dec 2025 reached $2.0 billion, down 17.41%, while the annual FY2025 figure was $2.0 billion, 17.41% down from the prior year.
Long-Term Deferred Tax reached $2.0 billion in Q4 2025 per GILD's latest filing, down from $2.0 billion in the prior quarter.
In the past five years, Long-Term Deferred Tax ranged from a high of $2.7 billion in Q2 2025 to a low of $2.0 billion in Q4 2025.